MedTrace Logo

Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections

NCT04458012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-07-07

No results posted yet for this study

Summary

To investigate prevalence of dry eye disease in Norwegian patients with age-related macular degeneration receiving intravitreal injections, as well as to reveal possible risk factors of DED in this population.

Conditions

  • Dry Eye

Interventions

DIAGNOSTIC_TEST

Oculus Keratograph. Schirmer test. Tear fluid sample.

Objective measurements of the ocular surface using Oculus 5 keratograph. Slit lamp examination and tear fluid sample using Schirmer strips.

Sponsors & Collaborators

  • Tor Paaske Utheim

    collaborator UNKNOWN

  • Vegard Asgeir Forsaa

    collaborator UNKNOWN

  • Vilde Marie Thomseth

    collaborator UNKNOWN

  • Helse Stavanger HF

    lead OTHER_GOV

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-25
Primary Completion
2023-06-25
Completion
2024-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04458012 on ClinicalTrials.gov